20Slash20 Inc., the creator of The Eye Drink, announced that it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, in New York City. CEO Dr. Roger Wu is set to deliver an investor presentation on Sept. 9 at 9:35 a.m. ET at The Westin New York Grand Central, followed by one-on-one meetings with investors.
The conference is designed to bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors, providing a platform for companies like 20Slash20 to showcase their innovations to a targeted audience of potential investors and partners.
The Eye Drink is positioned as the world’s first ready-to-drink functional beverage formulated specifically for individuals who spend extended hours on digital devices. With the pervasive use of smartphones and computers, screen-induced eye problems have become a growing concern. 20Slash20 aims to address this by offering a convenient and tasty solution that supports eye health through science-backed ingredients.
The significance of this presentation lies in the increasing attention to eye health in the digital age. As remote work and digital entertainment continue to rise, consumers are seeking proactive measures to mitigate the effects of prolonged screen time. The Eye Drink taps into this market by providing a functional beverage that fits into daily routines.
For 20Slash20, presenting at such a conference is an opportunity to gain visibility among investors focused on disruptive growth and life sciences. The company’s participation underscores its commitment to establishing The Eye Drink as a leading product in the functional beverage space, which has seen a surge in demand for health-oriented drinks.
The conference also serves as a networking venue where companies can forge strategic alliances, secure funding, and accelerate growth. For investors, it offers a chance to evaluate emerging companies with unique value propositions like The Eye Drink.
As the functional beverage market expands, products that address specific health concerns—such as eye strain from digital devices—are likely to attract consumer interest. 20Slash20’s presentation is expected to highlight the science behind The Eye Drink and its potential to capture a niche yet growing segment.
In a world where screens dominate daily life, the importance of eye health cannot be overstated. 20Slash20’s participation in this conference signals its intent to lead in this space, and the outcome of the presentation could influence the company’s trajectory in the competitive beverage industry.
